Glycaemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with Type 2 diabetes

被引：0
|
作者：
Dailey, G
Rosenstock, J
Moses, R
Ways, K
机构：
[1] Scripps Clin, Div Diabet & endocrinol, La Jolla, CA USA
[2] Dallas Diabet & Endocrine Ctr, Dallas, TX USA
[3] Illawarra Diabet Serv, Wollongong, NSW, Australia
[4] Aventis, Bridgewater, NJ USA
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
734
引用
收藏
页码：A265 / A266
页数：2
相关论文
共 50 条
  • [21] COST SAVINGS ASSOCIATED WITH PREMIX VERSUS BASAL-BOLUS REGIMEN IN ALGERIAN PATIENTS WITH TYPE 2 DIABETES INSUFFICIENTLY CONTROLLED UNDER BASAL INSULIN REGIMEN
    Sellam, Y.
    Belhadj, M.
    Brouri, M.
    Haddam, A. E. M.
    Malek, R.
    Semrouni, M.
    Zekri, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S583 - S583
  • [22] The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
    Castellano E.
    Attanasio R.
    Giagulli V.A.
    Boriano A.
    Terzolo M.
    Papini E.
    Guastamacchia E.
    Monti S.
    Aglialoro A.
    Agrimi D.
    Ansaldi E.
    Babini A.C.
    Blatto A.
    Brancato D.
    Casile C.
    Cassibba S.
    Crescenti C.
    De Feo M.L.
    Del Prete A.
    Disoteo O.
    Ermetici F.
    Fiore V.
    Fusco A.
    Gioia D.
    Grassi A.
    Gullo D.
    Lo Pomo F.
    Miceli A.
    Nizzoli M.
    Pellegrino M.
    Pirali B.
    Santini C.
    Settembrini S.
    Tortato E.
    Triggiani V.
    Vacirca A.
    Borretta G.
    [J]. Journal of Diabetes & Metabolic Disorders, 2018, 17 (2): : 393 - 399
  • [23] Efficacy and safety of post-meal insulin glulisine (GLU) compared with pre-meal regular human insulin (RHI) in a basal-bolus regimen with insulin glargine
    Garg, S
    Rosenstock, J
    Ways, K
    [J]. DIABETES, 2004, 53 : A125 - A125
  • [24] Efficacy and safety of insulin glulisine (GLU) versus insulin lispro (LIS) as part of a basal-bolus insulin regimen in children and adolescents with Type 1 diabetes (T1DM)
    Philotheou, A.
    Arslanian, S.
    Blatniczky, L.
    Peterkova, V.
    Souhami, E.
    Danne, T.
    [J]. DIABETIC MEDICINE, 2008, 25
  • [25] Continuous glucose monitoring improved glycaemic control in patients with type 1 diabetes during 52 weeks of insulin pump therapy as well as with basal-bolus insulin regimen
    Soupal, J.
    Flekac, M.
    Petruzelkova, L.
    Skrha, J., Jr.
    Skrha, J.
    Prazny, M.
    [J]. DIABETOLOGIA, 2015, 58 : S476 - S476
  • [26] A basal-bolus regimen of insulin glargine and insulin glulisine results in a lower rate of hypoglycaemia relative to endpoint HbA1c versus twice-daily premixed insulin in type 2 diabetes patients
    Fritsche, A.
    Larbig, M.
    Haering, H. -U.
    [J]. DIABETOLOGIA, 2010, 53
  • [27] Introduction of insulin glulisine in combination with insulin glargine to basal-bolus therapy improves metabolic control in patients with type 1 diabetes in everyday clinical practice
    Ruhnau, Klaus-Juergen
    [J]. DIABETES, 2006, 55 : A479 - A479
  • [28] Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen
    Efremova, N. V.
    Bolotskaya, L. L.
    Atarshchikov, D. S.
    Bondarenko, O. N.
    Ilyin, A. V.
    Shestakova, M. V.
    [J]. TERAPEVTICHESKII ARKHIV, 2015, 87 (10): : 42 - 49
  • [29] Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study
    Vellanki, Priyathama
    Cardona, Saumeth
    Galindo, Rodolfo J.
    Urrutia, Maria A.
    Pasquel, Francisco J.
    Davis, Georgia M.
    Fayfman, Maya
    Migdal, Alexandra
    Peng, Limin
    Umpierrez, Guillermo E.
    [J]. DIABETES CARE, 2022, 45 (10) : 2217 - 2223
  • [30] Insulin glulisine imparts effective glycaemic control in patients with Type 2 diabetes
    Rayman, Gerrard
    Profozic, Velimir
    Middle, Michelle
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (02) : 304 - 312
12345